People · Operator
Named in public records as an officer, director or promoter · active 2011–2018 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Uromedica Inc | — | Biotechnology | Seed | $2.4M | $26.6M | 2011 |
David C. Booth at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside David C. Booth on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| John H. Burton | 1 | 2 |
| Douglas H. Glader | 1 | 1 |
| Timothy C. Cook | 1 | 1 |
| John H. Haveman | 1 | 1 |
| Kerry C. Vermeer | 1 | 1 |
| JOHN L REINECK | 1 | 1 |
| DOUGLAS H GLADDER | 1 | 1 |
| Theodore H. Herzog | 1 | 1 |
| STEPHEN H CLARK | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.